Fragmin and Jaundice - yellow skin - a phase IV clinical study of FDA data

Summary:

Jaundice - yellow skin is reported as a side effect among people who take Fragmin (dalteparin sodium), especially for people who are female, 50-59 old, have been taking the drug for < 1 month also take Pantoprazole, and have High blood pressure.

The phase IV clinical study analyzes which people have Jaundice - yellow skin when taking Fragmin. It is created by eHealthMe based on reports of 11,893 people who have side effects when taking Fragmin from the FDA, and is updated regularly.

What is Fragmin?

Fragmin has active ingredients of dalteparin sodium. It is often used in deep venous thrombosis. eHealthMe is studying from 11,999 Fragmin users. Check the latest studies of Fragmin.

What is Jaundice - yellow skin?

Jaundice - yellow skin (a yellowish pigmentation of the skin) is found to be associated with 1,474 drugs and 3,052 conditions by eHealthMe. Check the latest studies of Jaundice - yellow skin.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 30, 2026

11,893 people reported to have side effects when taking Fragmin.
Among them, 72 people (0.61%) have Jaundice - yellow skin.

Could Fragmin cause Jaundice - yellow skin?

Among these 72 people:

How long have people been on Fragmin when they have Jaundice - yellow skin? *

What is the gender of people who have Jaundice - yellow skin when taking Fragmin? *

female: 69.57 %
male: 30.43 %

What is the age of people who have Jaundice - yellow skin when taking Fragmin? *

What are other drugs people take besides Fragmin? *

What are other side effects people have besides Jaundice - yellow skin? *

General Physical Health Deterioration (weak health status): 18 people, 25.00%
Fever: 14 people, 19.44%
Fatigue (feeling of tiredness): 13 people, 18.06%
Haemoglobin Decreased: 12 people, 16.67%
Hepatic Failure (liver failure): 12 people, 16.67%
Weakness: 11 people, 15.28%
Constipation: 11 people, 15.28%
Haemolytic Anaemia (anaemia due to haemolysis): 10 people, 13.89%
High Blood Pressure: 10 people, 13.89%
Diarrhea: 10 people, 13.89%

What are the existing conditions these people have? *

High Blood Pressure: 9 people, 12.50%
Metastases To Bone (cancer spreads to bone): 7 people, 9.72%
Carcinoid Tumor: 7 people, 9.72%
Metastatic Malignant Melanoma (spreadable cancer tumour of melanine): 6 people, 8.33%
Attention Deficit Hyperactivity Disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness): 5 people, 6.94%
Cardiac Failure: 4 people, 5.56%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 4 people, 5.56%
Breast Cancer Metastatic: 4 people, 5.56%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 4 people, 5.56%
Hyperkalemia (damage to or disease of the kidney): 3 people, 4.17%

* Approximation only. Some reports may have incomplete information.

Do you take Fragmin and have Jaundice - yellow skin?

- Check whether Jaundice - yellow skin is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Fragmin:

Fragmin (11,999 reports)

Browse all side effects of Fragmin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Jaundice - yellow skin:

Jaundice - yellow skin (1,474 drugs)

Browse all the conditions that are associated with Jaundice - yellow skin:

Jaundice - yellow skin (3,052 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on dalteparin sodium (the active ingredients of Fragmin) and Fragmin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.